COVID-19 vaccine induced prothrombotic immune thrombocytopenia.
作者信息
Xie Cheng, Vincent Laura, Chadwick Andrew, Peschl Heiko
机构信息
Department of Radiology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, UK.
出版信息
Eur Heart J. 2021 Aug 31;42(33):3206. doi: 10.1093/eurheartj/ehab237.
Abstract
摘要
相似文献
1
COVID-19 vaccine induced prothrombotic immune thrombocytopenia.新冠病毒疫苗诱导的血栓性免疫性血小板减少症
Eur Heart J. 2021 Aug 31;42(33):3206. doi: 10.1093/eurheartj/ehab237.
2
Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine.与Ad26.COV2.S（杨森；强生）疫苗相关的免疫介导性血小板减少症。
Am J Ther. 2021 Aug 20;28(5):e604-e606. doi: 10.1097/MJT.0000000000001431.
3
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom.英国新冠病毒感染相关肝素诱导的血小板减少症伴血栓形成与疫苗诱导的免疫性血小板减少症及血栓形成对比
Semin Thromb Hemost. 2024 Oct;50(7):1022-1025. doi: 10.1055/s-0044-1785484. Epub 2024 Apr 9.
4
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.继发于 COVID-19 疫苗接种的免疫性血小板减少症。
BMJ Case Rep. 2021 May 31;14(5):e242220. doi: 10.1136/bcr-2021-242220.
5
Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.关于先前发表的Epub手稿的通信：新型冠状病毒疫苗接种后免疫性血小板减少性紫癜
Br J Haematol. 2021 Sep;194(6):e93-e95. doi: 10.1111/bjh.17628. Epub 2021 Jun 10.
6
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.疫苗诱导的免疫性血小板减少症和血栓形成：英国国家卫生与临床优化研究所指南摘要
BMJ. 2021 Oct 1;375:n2195. doi: 10.1136/bmj.n2195.
7
Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.单侧线性紫癜性皮疹预示着新型冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e429-e431. doi: 10.1111/jdv.18014. Epub 2022 Feb 23.
8
Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency.疫苗诱导的血栓形成性免疫性血小板减少症（VIPIT）和疫苗诱导的血小板减少性血栓形成（VITT）的病理生理学及其在急诊中的诊断方法
Medicina (Kaunas). 2021 Sep 22;57(10):997. doi: 10.3390/medicina57100997.
9
VITT with inactivated SARS-CoV-2 vaccine - index case.接种过灭活 SARS-CoV-2 疫苗的 VITT - 首例病例。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2036556. doi: 10.1080/21645515.2022.2036556. Epub 2022 Mar 7.
10
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).接种 mRNA COVID-19 疫苗后出现的血小板减少症，包括免疫性血小板减少症，已向疫苗不良事件报告系统（VAERS）报告。
Vaccine. 2021 Jun 8;39(25):3329-3332. doi: 10.1016/j.vaccine.2021.04.054. Epub 2021 Apr 30.
引用本文的文献
1
The Impact of COVID-19 and the Practical Importance of Vaccinations and Nirmatrelvir/Ritonavir for Patients with Cardiovascular Disease.新冠病毒病（COVID-19）的影响以及疫苗接种和奈玛特韦/利托那韦对心血管疾病患者的实际重要性
Vaccines (Basel). 2025 May 23;13(6):554. doi: 10.3390/vaccines13060554.
2
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review.新型冠状病毒肺炎疫苗诱导的免疫性血栓性血小板减少症：综述
Clin Exp Vaccine Res. 2023 Oct;12(4):265-290. doi: 10.7774/cevr.2023.12.4.265. Epub 2023 Oct 31.
3
ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review.ChAdOx1新型冠状病毒疫苗与成人血栓形成伴血小板减少综合征：一项系统评价
Adv Pharm Bull. 2023 Nov;13(4):723-735. doi: 10.34172/apb.2023.081. Epub 2023 Apr 29.
4
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report.首例BNT162b2 mRNA疫苗（Comirnaty，辉瑞/ BioNTech）初种后多器官血栓形成的组织病理学TMA样分布：尸检病例报告
Thromb J. 2022 Oct 6;20(1):61. doi: 10.1186/s12959-022-00418-7.
5
Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review.冠状病毒疫苗接种后疫苗诱导的血栓性血小板减少症：一项叙述性综述。
Ann Med Surg (Lond). 2022 Jan;73:102988. doi: 10.1016/j.amsu.2021.102988. Epub 2021 Oct 30.
6
Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score.腺病毒 COVID-19 疫苗接种后血栓性血小板减少症的死亡率预测因素：FAPIC 评分。
Eur Heart J. 2021 Oct 14;42(39):4053-4063. doi: 10.1093/eurheartj/ehab592.
7
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.疑似 COVID-19 疫苗诱导（免疫性）血栓性血小板减少症的实验室检测。
Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17.
8
Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19.扩大由新冠病毒腺病毒载体疫苗引起的血栓性血小板减少综合征的临床谱。
Am J Emerg Med. 2022 Apr;54:318-319. doi: 10.1016/j.ajem.2021.05.053. Epub 2021 May 23.
Zotero 插件